Patent Notice

This web page satisfies the virtual patent marking provisions of various jurisdictions including the relevant provisions of the America Invents Act and provides the necessary notice under 35 U.S.C. § 287(a).

Certain of UroGen Pharma’s approved product(s)and their associated U.S. patents are set forth in the table below, the contents of which are subject to change due to issuance, licensing or expiration of patent rights, product changes or launches and other circumstances.The absence of a productor a U.S. Patent number from this list does not constitute a waiver of UroGen Pharma’s patent, trademark, or other intellectual property rights concerning that productor patent.

Product/Investigational Agent

Patent Number(s) in the USA

JELMYTO®(mitomycin) for pyelocalyceal solution